Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Gene variation affects prostate issues and hair loss.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

The study concluded that both estrogen and androgen receptors, which decrease with age, are linked to skin aging and may be hormonally regulated.

Testosterone therapy can help with androgen deficiency in women but should be used with caution and monitoring due to potential risks.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

Androgens can both increase and decrease hair growth in different parts of the body.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Male hormones cause different growth in identical human hair follicles due to their unique epigenetic characteristics.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Testosterone and DHEA can benefit women's health but must be prescribed carefully due to potential risks.

Different anti-androgen medications can help treat excessive hair growth, but the right choice depends on accurate diagnosis.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

COVID-19 may worsen with androgens; anti-androgen drugs could help.

Adding dutasteride to therapy may improve treatment for advanced salivary duct cancer.

AR gene variations don't affect aging markers in men.

Androgens may worsen COVID-19 and hair loss could indicate the disease's severity.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

MK-0773 safely increased muscle mass but did not improve muscle strength or function in elderly women with sarcopenia.

Androgen receptor signaling causes early aging of cells important for hair growth by damaging their DNA.

Menopausal women have higher androgen levels, which can cause symptoms like facial hair growth and low sexual desire.

Male hormones worsen kidney transplant damage, but blocking them helps.

Apigenin and ellagic acid may help manage PCOS symptoms.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

New treatments for hair loss may target specific pathways and generate new hair follicles.

We need better ways to test and understand SARMs to make safer and more effective treatments.

Women with keloid scars often have acne and hair loss, especially those with "true" keloids, indicating a possible hormonal imbalance.